A $79 million soybean processing facility is set to be constructed at the former Garan Manufacturing property in Kaplan, Louisiana, bringing 40-50 new jobs and revitalizing the long-vacant site ...

Samsung Biologics will acquire the Rockville assets for $280m, with closing expected by the end of first quarter of 2026.

To reset the laboratory space to an operational environment, TOMI’s iHP Corporate Service team will perform a comprehensive whole-facility fogging service. This service covers all critical areas, ...

Located in Rockville, Maryland, GSK's Human Genome Sciences will be Samsung Biologics' first U.S.-based manufacturing site. | ...

Samsung Biologics acquires Human Genome Sciences from GSK for $280 million, expanding its US manufacturing footprint. The ...

The Maryland life sciences campus is part of a package deal alongside Human Genome Sciences, which Samsung is acquiring from ...

Samsung Biologics America, a subsidiary of Samsing Biologics, a CDMO, has entered into a definitive agreement to acquire 100% ...

Under the ongoing collaboration Remedy Cell’s personnel, along with Pluri’s Contract Development and Manufacturing Organization (“CDMO”) division (PluriCDMO™), have successfully completed the full ...

Samsung Biologics will acquire a drug manufacturing facility in the United States from GlaxoSmithKline for $280 million, ...

Secures the company's first U.S.-based manufacturing site, strengthening and diversifying its global supply networkAdditional investments planned to expand the site's capacity (currently at 60,000 ...

PRNewswire/ - AtomVie Global Radiopharma (AtomVie), a global radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing and clinical supply, is ...